A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211
Investigations on dose deposition in superficial bladder lesions following endocavitary administration were presented at EANM 2026 congress, in Vienna. This…
Discover the impact of astatine-211 on bladder cancer · Learn more

Investigations on dose deposition in superficial bladder lesions following endocavitary administration were presented at EANM 2026 congress, in Vienna. This…

The media outlet L’Usine Nouvelle highlights our innovation strategy and the key role that Framatome / IBA’s future cyclotron in…

This issue takes a deep dive into one of the most dynamic areas of precision oncology. MabDesign’s Scientific and Business…

Dr. Alexandra Paillard (Giteau) Dr. Jean-François Chatal Dr. Jacques Barbet Atonco SAS www.atonco-pharma.com Disclaimer This report has been compiled by…